LATAM: Mercado de prescripción crecerá 10% anual hasta 2013...(III)

The report also notes that:




- Cuba has a relatively strong pharmaceutical and biotechnological industry, and domestic production accounts for 80%-90% of the domestic market, which has been valued at US$501 million for 2009;


- Peru produces little in the way of pharmaceutical exports. Imports of original drugs are almost exclusively purchased by the private pharmacy sector, whilst locally-produced branded and unbranded generics are consumed by the private pharmacy and public sectors; and


- Venezuela’s recent economic outperformance has boosted out-of-pocket drug spending in the private sector, while health care reforms have also increased drug expenditure, particularly in the public sector. The market has grown both in value and volume, as generics consumption has risen amongst previously-excluded populations. However, market growth is expected to fall as the economy deepens into recession in 2010.
By Lynne Taylor

Ver...

Ver anterior...